Biomolecular strategy for designing antibiotic–silver nanoparticles conjugate via nitrate reductase mediated β-lactamase inhibition with molecular docking insights

1. Siddiqi, K. S., Husen, A. & Rao, R. A. K. A review on biosynthesis of silver nanoparticles and their biocidal properties. J. Nanobiotechnol. 16, 14. https://doi.org/10.1186/s12951-018-0334-5 (2018).

   Google Scholar 

2. Choudhary, S. et al. Phyco-synthesis of silver nanoparticles by environmentally safe approach and their applications. Sci. Rep. 14, 9568. https://doi.org/10.1038/s41598-024-60195-3 (2024).

   Google Scholar 

3. Rafique, M., Sadaf, I., Rafique, M. S. & Tahir, M. B. A review on green synthesis of silver nanoparticles and their applications. Artif. Cells Nanomed. Biotechnol. 45, 1272–1291. https://doi.org/10.1080/21691401.2016.1241792 (2016).

   Google Scholar 

4. Nguyen, N. P. U., Dang, N. T., Doan, L. & Nguyen, T. T. H. Synthesis of silver nanoparticles: from conventional to ‘modern’ methods—a review. Processes. 11, 2617. https://doi.org/10.3390/pr11092617 (2023).

5. Duman, H. et al. Silver nanoparticles: a comprehensive review of synthesis methods and chemical and physical properties. Nanomaterials 14, 1527. https://doi.org/10.3390/nano14181527 (2024).

   Google Scholar 

6. Dhaka, A., Mali, S. C., Sharma, S. & Trivedi, R. A review on biological synthesis of silver nanoparticles and their potential applications. Results Chem. 6, 101108. https://doi.org/10.1016/j.rechem.2023.101108 (2023).

   Google Scholar 

7. Arshad, F. et al. Bioinspired and green synthesis of silver nanoparticles for medical applications: a green perspective. Appl. Biochem. Biotechnol. 196, 3636–3669. https://doi.org/10.1007/s12010-023-04719-z (2024).

   Google Scholar 

8. El deeb, B. A., Faheem, G. G. & Bakhit, M. S. Biosynthesis of silver nanoparticles by Talaromyces funiculosus for therapeutic applications and safety evaluation. Sci. Rep. 15, 13750. https://doi.org/10.1038/s41598-025-95899-7 (2025).

   Google Scholar 

9. Shaligram, N. S. et al. Biosynthesis of silver nanoparticles using aqueous extract from the compactin producing fungal strain. Process. Biochem. 44, 939–943. https://doi.org/10.1016/j.procbio.2009.04.009 (2009).

   Google Scholar 

10. El deeb, B. A., Faheem, G. G. & Bakhit, M. S. Antimicrobial activities of biogenic silver nanoparticles synthesized by Curvularia spicifera. Sohag J. Sci. 10, 95–102. https://doi.org/10.21608/sjsci.2024.336812.1233 (2025).

    Google Scholar 

11. Raghav, D., Jyoti, A., Siddiqui, A. J. & Saxena, J. Plant-associated endophytic fungi as potential bio‐factories for extracellular enzymes: progress, challenges and strain improvement with precision approaches. J. Appl. Microbiol. 133, 287–310. https://doi.org/10.1111/jam.15574 (2022).

    Google Scholar 

12. Wijesekara, T. & Xu, B. Health-promoting effects of bioactive compounds from plant endophytic fungi. J. Fungi. 9, 997. https://doi.org/10.3390/jof9100997 (2023).

    Google Scholar 

13. Usman, M. et al. Synergistic partnerships of endophytic fungi for bioactive compound production and biotic stress management in medicinal plants. Plant. Stress. 11, 100425. https://doi.org/10.1016/j.stress.2024.100425 (2024).

    Google Scholar 

14. Kumar, A. S. et al. Nitrate reductase-mediated synthesis of silver nanoparticles from AgNO₃. Biotechnol. Lett. 29, 439–445. https://doi.org/10.1007/s10529-006-9256-7 (2007).

    Google Scholar 

15. Phanjom, P. & Ahmed, G. Biosynthesis of silver nanoparticles by Aspergillus oryzae (MTCC 1846) and its characterizations. Nanosci. Nanotechnol. 5, 14–21. https://doi.org/10.5923/j.nn.20150501.03 (2015).

    Google Scholar 

16. Mikhailova, E. O. Green silver nanoparticles: an antibacterial mechanism. Antibiotics 14, 5. https://doi.org/10.3390/antibiotics14010005 (2025).

    Google Scholar 

17. Abdelmoneim, H. M., Taha, T. H., Elnouby, M. S. & AbuShady, H. M. Extracellular biosynthesis, OVAT/statistical optimization, and characterization of silver nanoparticles (AgNPs) using Leclercia adecarboxylata THHM and its antimicrobial activity. Microb. Cell. Fact. 21, 277. https://doi.org/10.1186/s12934-022-01998-9 (2022).

    Google Scholar 

18. Jargeat, P. et al. Characterisation and expression analysis of a nitrate transporter and nitrite reductase genes, two members of a gene cluster for nitrate assimilation from the symbiotic basidiomycete Hebeloma cylindrosporum. Curr. Genet. 43, 199–205. https://doi.org/10.1007/s00294-003-0387-2 (2003).

    Google Scholar 

19. Khodashenas, B. Nitrate reductase enzyme in Escherichia coli and its relationship with the synthesis of silver nanoparticles. UCT J. Resea Scien Eng. Techno. 3, 26–32 (2015).

    Google Scholar 

20. Gholami-Shabani, M. et al. Antimicrobial activity and physical characterization of silver nanoparticles green synthesized using nitrate reductase from Fusarium oxysporum. Appl. Biochem. Biotechnol. 172, 4084–4098. https://doi.org/10.1007/s12010-014-0809-2 (2014).

    Google Scholar 

21. Durán, N., Marcato, P. D., Alves, O. L., De Souza, G. I. & Esposito, E. Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains. J. Nanobiotechnol. 3, 8. https://doi.org/10.1186/1477-3155-3-8 (2005).

    Google Scholar 

22. Thepbandit, W. et al. Bio-synthesis and characterization of silver nanoparticles from Trichoderma species against cassava root rot disease. Sci. Rep. 14, 12535. https://doi.org/10.1038/s41598-024-60903-z (2024).

    Google Scholar 

23. Sidhu, A. K., Verma, N. & Kaushal, P. Role of biogenic capping agents in the synthesis of metallic nanoparticles and evaluation of their therapeutic potential. Front. Nanotechnol. 3, 801620. https://doi.org/10.3389/fnano.2021.801620 (2021).

    Google Scholar 

24. Acharya, C. et al. Synthesis of metallic nanoparticles using biometabolites: mechanisms and applications. Biometals 38, 21–54. https://doi.org/10.1007/s10534-024-00642-w (2025).

    Google Scholar 

25. Zaki, A. et al. Synthesis, purification and characterization of Plectonema derived AgNPs with elucidation of the role of protein in nanoparticle stabilization. RSC Adv. 12, 2497–2510. https://doi.org/10.1039/D1RA08396A (2022).

    Google Scholar 

26. Wypij, M. et al. Green synthesized silver nanoparticles: antibacterial and anticancer activities, biocompatibility, and analyses of surface-attached proteins. Front. Microbiol. 12, 632505. https://doi.org/10.3389/fmicb.2021.632505 (2021).

    Google Scholar 

27. Nobahar, A., Carlier, J. D., Miguel, M. G. & Costa, M. C. A review of plant metabolites with metal interaction capacity: a green approach for industrial applications. Biometals 34, 761–793. https://doi.org/10.1007/s10534-021-00315-y (2021).

    Google Scholar 

28. Vanaja, M. et al. Fungal assisted intracellular and enzyme based synthesis of silver nanoparticles and its bactericidal efficiency. Inter Res. J. Pharm. Biosci. 2, 8–19 (2015).

    Google Scholar 

29. Guilger-Casagrande, M. et al. Biosynthesis of silver nanoparticles employing Trichoderma harzianum with enzymatic stimulation for the control of Sclerotinia sclerotiorum. Sci. Rep. 9, 14351. https://doi.org/10.1038/s41598-019-50871-0 (2019).

    Google Scholar 

30. Menichetti, A., Mavridi-Printezi, A., Mordini, D. & Montalti, M. Effect of size, shape and surface functionalization on the antibacterial activity of silver nanoparticles. J. Funct. Biomater. 14, 244. https://doi.org/10.3390/jfb14050244 (2023).

    Google Scholar 

31. Shumi, G. et al. Biosynthesis of silver nanoparticles functionalized with histidine and phenylalanine amino acids for potential antioxidant and antibacterial activities. ACS Omega. 8, 24371–24386. https://doi.org/10.1021/acsomega.3c01910 (2023).

    Google Scholar 

32. Rogowska, A. et al. Silver nanoparticles functionalized with ampicillin. Electrophoresis 38, 2757–2764. https://doi.org/10.1002/elps.201700093 (2017).

    Google Scholar 

33. Khairnar, S. V., Das, A., Oupický, D., Sadykov, M. & Romanova, S. Strategies to overcome antibiotic resistance: silver nanoparticles and vancomycin in pathogen eradication. RSC Pharm. 2, 455–479. https://doi.org/10.1039/D4PM00314D (2025).

    Google Scholar 

34. Pammi, S. V. N. et al. Unlocking the synergistic potential of green metallic nanoparticles and antibiotics for antibacterial and wound healing activities. iScience. 28, 112518. https://doi.org/10.1016/j.isci.2025.112518 (2025).

35. Ghaffar, N. et al. Restoration of antibacterial activity of inactive antibiotics via combined treatment with AgNPs. ACS Omega. 9, 13621–13635. https://doi.org/10.1021/acsomega.3c07000 (2024).

    Google Scholar 

36. Murei, A., Ayinde, W. B., Gitari, M. W. & Samie, A. Functionalization and antimicrobial evaluation of ampicillin, penicillin and vancomycin with Pyrenacantha grandiflora Baill and silver nanoparticles. Sci. Rep. 10, 11596. https://doi.org/10.1038/s41598-020-68290-x (2020).

    Google Scholar 

37. Shungube, M. et al. Synthesis and biological evaluation of novel β-lactam-metallo β-lactamase inhibitors. RSC Adv. 13, 18991–19001. https://doi.org/10.1039/D3RA02490C (2023).

    Google Scholar 

38. Le Terrier, C. et al. Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor xeruborbactam in comparison with Taniborbactam against metallo-β-lactamases produced in Escherichia coli and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 68, e01570–e01523. https://doi.org/10.1128/aac.01570-23 (2024).

    Google Scholar 

39. Mustapha, A. et al. Phytochemical composition, in silico molecular docking analysis and antibacterial activity of Lawsonia inermis Linn leaves extracts against extended spectrum beta-lactamases-producing strains of Klebsiella pneumoniae. BioMed 4, 277–292. https://doi.org/10.3390/biomed4030022 (2024).

    Google Scholar 

40. Carcione, D., Siracusa, C., Sulejmani, A., Leoni, V. & Intra, J. Old and new beta-lactamase inhibitors: molecular structure, mechanism of action, and clinical use. Antibiotics 10, 995. https://doi.org/10.3390/antibiotics10080995 (2021).

    Google Scholar 

41. Sharma, D. et al. Unveiling the nanoworld of antimicrobial resistance: integrating nature and nanotechnology. Front. Microbiol. 15, 1391345. https://doi.org/10.3389/fmicb.2024.1391345 (2025).

    Google Scholar 

42. Herrera-Hidalgo, L. et al. Ampicillin and ceftriaxone solution stability at different temperatures in outpatient parenteral antimicrobial therapy. Antimicrob. Agents Chemother. 64, e00309–e00320. https://doi.org/10.1128/AAC.00309-20 (2020).

    Google Scholar 

43. Tigabie, M. et al. Colonization with extended-spectrum β-lactamase and carbapenemase-producing enterobacterales in Ethiopia: a systematic review and meta-analysis. PLoS ONE. 20, e0316492. https://doi.org/10.1371/journal.pone.0316492 (2025).

    Google Scholar 

44. Egorov, A. M., Ulyashova, M. M. & Rubtsova, M. Y. Inhibitors of β-lactamases. New life of β-lactam antibiotics. Biochem. Mosc. 85, 1292–1309. https://doi.org/10.1134/S0006297920110024 (2020).

    Google Scholar 

45. Katsarou, A., Stathopoulos, P., Tzvetanova, I. D., Asimotou, C. M. & Falagas, M. E. β-lactam/β-lactamase inhibitor combination antibiotics under development. Pathogens 14, 168. https://doi.org/10.3390/pathogens14020168 (2025).

    Google Scholar 

46. Elumalai, L. et al. Biosynthesis of actinobacterial mediated silver nanoparticle (AgNPs): therapeutic potential and in-silico docking analysis on targeted virulence receptor. J. Sol-Gel Sci. Technol. 111, 293–308. https://doi.org/10.1007/s10971-024-06441-6 (2024).

    Google Scholar 

47. Ramezanpour, M. et al. Computational and experimental approaches for investigating nanoparticle-based drug delivery systems. Biochim. Biophys. Acta Biomembr. 1858, 1688–1709. https://doi.org/10.1016/j.bbamem.2016.02.028 (2016).

    Google Scholar 

48. Aarón, R. H. et al. In Silico strategies for drug discovery: optimizing natural compounds from foods for therapeutic applications. Discov. Chem. 2, 133. https://doi.org/10.1007/s44371-025-00201-3 (2025).

49. Kleandrova, V. V., Cordeiro, M. N. D. & Speck-Planche, A. In silico approach for antibacterial discovery: PTML modeling of virtual multi-strain inhibitors against Staphylococcus aureus. Pharmaceuticals. 18, 196. https://doi.org/10.3390/ph18020196 (2025).

50. Jini, D., Sharmila, S., Anitha, A., Pandian, M. & Rajapaksha, R. M. H. In vitro and in Silico studies of silver nanoparticles (AgNPs) from Allium sativum against diabetes. Sci. Rep. 12, 22109. https://doi.org/10.1038/s41598-022-24818-x (2022).

    Google Scholar 

51. Ugbaja, S. C., Mushebenge, A. G. A., Kumalo, H., Ngcobo, M. & Gqaleni, N. Potential benefits of in silico methods: a promising alternative in natural compound’s drug discovery and repurposing for HBV therapy. Pharmaceuticals 18, 419. https://doi.org/10.3390/ph18030419 (2025).

    Google Scholar 

52. Dalbanjan, N. P. et al. In-silico strategies in nano-drug design: bridging nanomaterials and pharmacological applications. Nano TransMed. 4, 100091. https://doi.org/10.1016/j.ntm.2025.100091 (2025).

    Google Scholar 

53. Kar, P., Oriola, A. O. & Oyedeji, A. O. Molecular docking approach for biological interaction of green synthesized nanoparticles. Molecules 29, 2428. https://doi.org/10.3390/molecules29112428 (2024).

    Google Scholar 

54. Chowdhury, S., Basu, A. & Kundu, S. Green synthesis of protein capped silver nanoparticles from phytopathogenic fungus Macrophomina phaseolina (Tassi) goid with antimicrobial properties against multidrug-resistant bacteria. Nanoscale Res. Lett. 9, 365 (2014). http://www.nanoscalereslett.com/content/9/1/365

    Google Scholar 

55. Jain, N., Bhargava, A., Majumdar, S., Tarafdar, J. C. & Panwar, J. Extracellular biosynthesis and characterization of silver nanoparticles using Aspergillus flavus NJP08: a mechanism perspective. Nanoscale 3, 635–641. https://doi.org/10.1039/C0NR00656D (2011).

    Google Scholar 

56. Zhao, L., Gong, K., Wang, Y. & Kong, S. Rapid and environment-friendly preparation of silver nanoparticles and their inhibition against phytopathogenic fungi. Micro Nano Lett. 16, 213–220. https://doi.org/10.1049/mna2.12027 (2021).

    Google Scholar 

57. Sable, S. V., Kawade, S., Ranade, S. & Joshi, S. Bioreduction mechanism of silver nanoparticles. Mater. Sci. Eng. C. 107, 110299. https://doi.org/10.1016/j.msec.2019.110299 (2020).

    Google Scholar 

58. Babu, P. J. et al. Advances in nano silver-based biomaterials and their biomedical applications. Eng. Regen. 5, 326–341. https://doi.org/10.1016/j.engreg.2024.07.001 (2024).

    Google Scholar 

59. Saifuddin, N., Wong, C. W. & Yasumira, A. N. Rapid biosynthesis of silver nanoparticles using culture supernatant of bacteria with microwave irradiation. J. Chem. 6, 61–70. https://doi.org/10.1155/2009/734264 (2009).

    Google Scholar 

60. Fernández, J. G. et al. Production of silver nanoparticles using yeasts and evaluation of their antifungal activity against phytopathogenic fungi. Process. Biochem. 51, 1306–1313. https://doi.org/10.1016/j.procbio.2016.05.021 (2016).

    Google Scholar 

61. Hamedi, S., Ghaseminezhad, M., Shokrollahzadeh, S. & Shojaosadati, A. S. Controlled biosynthesis of silver nanoparticles using nitrate reductase enzyme induction of filamentous fungus and their antibacterial evaluation. Artif. Cells Nanomed. Biotechnol. 45, 1588–1596. https://doi.org/10.1080/21691401.2016.1267011 (2017).

    Google Scholar 

62. Vahabi, K., Mansoori, G. A. & Karimi, S. Biosynthesis of silver nanoparticles by fungus Trichoderma reesei (a route for large-scale production of AgNPs). Insciences J. 1, 65–79. https://doi.org/10.5640/insc.010165 (2011).

    Google Scholar 

63. Zomorodian, K. et al. Biosynthesis and characterization of silver nanoparticles by Aspergillus species. Biomed. Res. Int. 5435397 https://doi.org/10.1155/2016/5435397 (2016). (2016).

64. Hemath Naveen, K. S., Kumar, G., Karthik, L. & Bhaskara Rao, K. V. Extracellular biosynthesis of silver nanoparticles using the filamentous fungus Penicillium sp. Arch. Appl. Sci. Res. 2, 161–167 (2010). https://sid.ir/paper/662104/en

    Google Scholar 

65. El-Dein, M. M. N., Baka, Z. A., Abou-Dobara, M. I., El-Sayed, A. K. & El-Zahed, M. M. Extracellular biosynthesis, optimization, characterization and antimicrobial potential of Escherichia coli D8 silver nanoparticles. J. Microbiol. Biotechnol. Food Sci. 10, 648–656. https://doi.org/10.15414/jmbfs.2021.10.4.648-656 (2021).

    Google Scholar 

66. Onyangore, H. D. M., Andala, D. & Ndangili, P. Synthesis and conjugation of silver nanoparticles with beta ampicillin (2) antibiotic. G S J. 10, 1623–1650 (2022).

    Google Scholar 

67. Al-Ogaidi, I. A. Z. Detecting the antibacterial activity of green synthesized silver (Ag) nanoparticles functionalized with ampicillin (Amp). Baghdad Sci. J. 14, 117–125. https://doi.org/10.21123/bsj.2017.14.1.0117 (2017).

    Google Scholar 

68. Hadi, A. A. et al. Synergistic antibacterial effect of Persicaria odorata synthesised silver nanoparticles with antibiotics on drug-resistant bacteria. Inorg Chem Commun. 159, 111725. https://doi.org/10.1016/j.inoche.2023.111725 (2024).

    Google Scholar 

69. Adil, M. et al. Efficient green silver nanoparticles-antibiotic combinations against antibiotic-resistant bacteria. AMB Express. 13, 115. https://doi.org/10.1186/s13568-023-01619-7 (2023).

    Google Scholar 

70. Ibraheem, D. R. et al. Ciprofloxacin-loaded silver nanoparticles as potent nano-antibiotics against resistant pathogenic bacteria. Nanomaterials 12, 2808. https://doi.org/10.3390/nano12162808 (2022).

    Google Scholar 

71. Hasoon, B. A. et al. Silver nanoparticles conjugated amoxicillin: a promising nano-suspension for overcoming multidrug resistance bacteria and preservation of endotracheal tube. Inorg Chem Commun. 165, 112456. https://doi.org/10.1016/j.inoche.2024.112456 (2024).

    Google Scholar 

72. Masri, A. et al. Silver nanoparticle conjugation-enhanced antibacterial efficacy of clinically approved drugs cephradine and vildagliptin. Antibiotics 7, 100. https://doi.org/10.3390/antibiotics7040100 (2018).

    Google Scholar 

73. Hur, Y. E. et al. One-step functionalization of gold and silver nanoparticles by ampicillin. Mater. Lett. 129, 185–190. https://doi.org/10.1016/j.matlet.2014.05.032 (2014).

    Google Scholar 

74. Khatoon, N., Alam, H., Khan, A., Raza, K. & Sardar, M. Ampicillin silver nanoformulations against multidrug resistant bacteria. Sci. Rep. 9, 6848. https://doi.org/10.1038/s41598-019-43309-0 (2019).

    Google Scholar 

75. Brown, A. N. et al. Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl. Environ. Microbiol. 78, 2768–2774. https://doi.org/10.1128/AEM.06513-11 (2012).

    Google Scholar 

76. Ribeiro, A. I., Dias, A. M. & Zille, A. Synergistic effects between metal nanoparticles and commercial antimicrobial agents: a review. ACS Appl Nano Mater. 5, 3030–3064. https://doi.org/10.1021/acsanm.1c03891 (2022).

    Google Scholar 

77. Lopez-Carrizales, M. et al. In vitro synergism of silver nanoparticles with antibiotics as an alternative treatment in multiresistant uropathogens. Antibiotics 7, 50. https://doi.org/10.3390/antibiotics7020050 (2018).

    Google Scholar 

78. Buszewski, B., Rafiſska, K., Pomastowski, P., Walczak, J. & Rogowska, A. Novel aspects of silver nanoparticles functionalization. Colloids Surf. Physicochem Eng. Asp. 506, 170–178. https://doi.org/10.1016/j.colsurfa.2016.05.058 (2016).

    Google Scholar 

79. Jalil, K. et al. Excellent antibacterial and anti-inflammatory efficacy of amoxicillin by AgNPs and their conjugates synthesized using Micromeria biflora crude flavonoid extracts. Heliyon 10, e36752. https://doi.org/10.1016/j.heliyon.2024.e36752 (2024).

    Google Scholar 

80. Niu, L. et al. Silver nanoparticles derived from Streptomyces sp. YJD18 with multifunctional biomedical applications. Sci. Rep. 15, 18139. https://doi.org/10.1038/s41598-025-02925-9 (2025).

    Google Scholar 

81. Rudrappa, M. et al. Myco-nanofabrication of silver nanoparticles by Penicillium brasilianum NP5 and their antimicrobial, photoprotective and anticancer effect on MDA-MB-231 breast cancer cell line. Antibiotics 12, 567. https://doi.org/10.3390/antibiotics12030567 (2023).

    Google Scholar 

82. Raffanti, J. E. F. & King, J. C. Effect of pH on the stability of sodium ampicillin solutions. Am. J. Health-Syst Pharm. 31, 745–751. https://doi.org/10.1093/ajhp/31.8.745 (1974).

    Google Scholar 

83. Mitchell, S. M., Ullman, J. L., Teel, A. L. & Watts, R. J. pH and temperature effects on the hydrolysis of three β-lactam antibiotics: ampicillin, cefalotin and cefoxitin. Sci. Total Environ. 466–467, 547–555. https://doi.org/10.1016/j.scitotenv.2013.06.027 (2014).

    Google Scholar 

84. Fernández-Rubio, B. et al. Stability of ampicillin plus ceftriaxone combined in elastomeric infusion devices for outpatient parenteral antimicrobial therapy. Antibiotics 12, 432. https://doi.org/10.3390/antibiotics12030432 (2023).

    Google Scholar 

85. Zendegani, E. & Dolatabadi, S. The efficacy of imipenem conjugated with synthesized silver nanoparticles against Acinetobacter baumannii clinical isolates, Iran. Biol. Trace Elem. Res. 197, 330–340. https://doi.org/10.1007/s12011-019-01962-6 (2020).

    Google Scholar 

86. Zimet, P. et al. Biogenic silver nanoparticles conjugated with nisin: improving the antimicrobial and antibiofilm properties of nanomaterials. Chemistry 3, 1271–1285. https://doi.org/10.3390/chemistry3040092 (2021).

    Google Scholar 

87. Alfahad, M. A., Al-Hayanni, H. S. & Alnuaimi, M. T. Antibacterial activity of biologically synthesized silver nanoparticles using seeds extract of coated on Nigella sativa antibiotics against antibiotic-resistant Salmonella Typhi. Indian J. Ecol. 49, 396–402 (2022).

    Google Scholar 

88. Shahbandeh, M. et al. Conjugation of Imipenem to silver nanoparticles for enhancement of its antibacterial activity against multidrug-resistant isolates of Pseudomonas aeruginosa. J. Biosci. 46, 26. https://doi.org/10.1007/s12038-021-00143-9 (2021).

    Google Scholar 

89. Veerapandian, M., Lim, S. K., Nam, H. M., Kuppannan, G. & Yun, K. S. Glucosamine-functionalized silver glyconanoparticles: characterization and antibacterial activity. Anal. Bioanal Chem. 398, 867–876. https://doi.org/10.1007/s00216-010-3964-5 (2010).

    Google Scholar 

90. Zharkova, M. S. et al. Silver nanoparticles functionalized with antimicrobial polypeptides: benefits and possible pitfalls of a novel antiinfective tool. Front. Microbiol. 12, 750556. https://doi.org/10.3389/fmicb.2021.750556 (2021).

    Google Scholar 

91. Veerapandian, M. & Yun, K. Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications. Appl. Microbiol. Biotechnol. 90, 1655–1667. https://doi.org/10.1007/s00253-011-3291-6 (2011).

    Google Scholar 

92. Joshi, T., Jinugu, E. M., Khristi, A., Thareja, P. & Bagchi, D. Non-toxic, printable starch hydrogel composite with surface functionalized silver nanoparticles having wide-spectrum antimicrobial property. BioNanoSci 14, 4442–4455. https://doi.org/10.1007/s12668-024-01491-0 (2024).

    Google Scholar 

93. Zhang, T. et al. A novel tri-mode detection platform for ampicillin and drug resistance genes by CRISPR-driven luminescent nanozymes. J. Nanobiotechnol. 23, 346. https://doi.org/10.1186/s12951-025-03454-3 (2025).

    Google Scholar 

94. Vassallo, A., Silletti, M. F., Faraone, I. & Milella, L. Nanoparticulate antibiotic systems as antibacterial agents and antibiotic delivery platforms to fight infections. J. Nanomater. 2020, 6905631. https://doi.org/10.1155/2020/6905631 (2020).

95. Ahmed, V. et al. Functionalised iron nanoparticle–penicillin G conjugates: a novel strategy to combat the rapid emergence of β-lactamase resistance among infectious micro-organism. J. Exp. Nanosci. 10, 718–728. https://doi.org/10.1080/17458080.2014.881570 (2015).

    Google Scholar 

96. Drawz, S. M. & Bonomo, R. A. Three decades of β-lactamase inhibitors. Clin. Microbiol. Rev. 23, 160–201. https://doi.org/10.1128/cmr.00037-09 (2010).

    Google Scholar 

97. Therrien, C. & Levesque, R. C. Molecular basis of antibiotic resistance and β-lactamase inhibition by mechanism-based inactivators: perspectives and future directions. FEMS Microbiol. Rev. 24, 251–262. https://doi.org/10.1111/j.1574-6976.2000.tb00541.x (2000).

    Google Scholar 

98. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685. https://doi.org/10.1038/227680a0 (1970).

    Google Scholar 

99. Munir, I. & Yesiloz, G. Novel size-tunable and straightforward ultra-small nanoparticle synthesis in a varying concentration range of glycerol as a green reducing solvent. Acs Omega. 8, 28456–28466. https://doi.org/10.1021/acsomega.3c02697 (2023).

    Google Scholar 

100. Guex, N., Peitsch, M. C. & Schwede, T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss‐Pdb viewer: a historical perspective. Electrophoresis 30, S162–S173. https://doi.org/10.1002/elps.200900140 (2009).

     Google Scholar 

101. Kumar, M. & Rathore, R. S. RamPlot: a webserver to draw 2D, 3D and assorted Ramachandran (φ, ψ) maps. J. Appl. Cryst. 58, 630–636. https://doi.org/10.1107/S1600576725001669 (2025).

     Google Scholar 

102. Chandrasekhar, I. et al. A consistent potential energy parameter set for lipids: dipalmitoylphosphatidylcholine as a benchmark of the GROMOS96 45A3 force field. Eur. Biophys. J. 32, 67–77. https://doi.org/10.1007/s00249-002-0269-4 (2003).

     Google Scholar 

103. Ismael, M., Eladel, E., El-Taher, M. A. E. D. & Gad, A. A. M. Structural design, and biological assessment of Co. Ni2+ Cu2+ Zn2+ Complexes N-(phenyl)-2-imino-2H-chromene-3-carboxamide Inorg. Chem. Commun. 158, 111492. https://doi.org/10.1016/j.inoche.2023.111492 (2023).

     Google Scholar 

104. Lang, P. T. et al. DOCK 6: combining techniques to model RNA–small molecule complexes. RNA 15, 1219–1230. https://doi.org/10.1261/rna.1563609 (2009).

     Google Scholar 

105. Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand–protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778–2786. https://doi.org/10.1021/ci200227u (2011).

     Google Scholar 

106. Boudreau, M. D. et al. Differential effects of silver nanoparticles and silver ions on tissue accumulation, distribution, and toxicity in the Sprague Dawley rat following daily oral gavage administration for 13 weeks. Toxicol. Sci. 150, 131–160. https://doi.org/10.1093/toxsci/kfv318 (2016).

     Google Scholar 

107. Kowalska-Krochmal, B. & Dudek-Wicher, R. The minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance. Pathogens 10, 165. https://doi.org/10.3390/pathogens10020165 (2021).

     Google Scholar 

108. Singh, S., Kuca, K. & Kalia, A. Alterations in growth and morphology of Ganoderma lucidum and Volvariella volvaceae in response to nanoparticle supplementation. Mycobiology 48, 383–391. https://doi.org/10.1080/12298093.2020.1809613 (2020).

     Google Scholar 

109. Sharma, S. et al. Staphylococcus aureus including MRSA nasal carriage among hospital exposed and unexposed medical students. J. Family Med. Prim. Care. 9, 4936–4941. https://doi.org/10.4103/jfmpc.jfmpc_820_20 (2020).

     Google Scholar 

110. Aliyu, Y. et al. Determination of antibiotic resistance patterns of beta-lactamase-producing Escherichia coli strains from Kindirmo in Nasarawa Ttown, Nasarawa State, Nigeria. UMYU J. Microbiol. Res. 9, 201–206. https://doi.org/10.47430/ujmr.2493.024 (2024).

     Google Scholar 

111. Lumivero XLSTAT statistical and data analysis solution. https://www.xlstat.com/en (2024)

Download references